United Therapeutics (UTHR) news

United Therapeutics Corporation: RBC raises target price to $708 from $677

United Therapeutics Corporation: JP Morgan raises target price to $710 from $687

JP Morgan has revised its price target for United Therapeutics Corporation (NASDAQ: UTHRX) to $710 from $687, reflecting a positive reassessment of the company’s outlook. The adjustment comes amid ongoing market activity involving the biopharmaceutical firm, which has been a notable performer in…

Collplant Biotechnologies - Unit files U.S. provisional patent application expanding photonic computing platform

CollPlant Biotechnologies, a regenerative and aesthetic medicine company, has filed a U.S. provisional patent application that expands its photonic computing platform, signaling continued innovation in its 3D bioprinting and tissue engineering technologies. The filing is part of the company’s…

United Therapeutics (UTHR) fell 5.13% in intraday trading after rising 5.44% on Thursday, marking a reversal of the prior session's move.

United Therapeutics (UTHR) shares declined 5.13% in intraday trading on Friday, reversing a 5.44% gain recorded on the previous session. The stock's performance reflects ongoing volatility in the biopharmaceutical sector, though no recent earnings reports or major news events have been disclosed…

Liquidia Corporation: Wells Fargo cuts to equal weight from overweight

Wells Fargo has adjusted its stance on Liquidia Corporation (NASDAQ:LQDA), downgrading the stock to "Equal Weight" , according to recent reports. This move reflects a recalibration of the firm’s outlook on the company’s competitive positioning and growth potential in the pulmonary hypertension…